BPC-157
Price data
| Time | Chance of yes |
|---|---|
| now | 75% |
| 18 Nov, 16:19 UTC | 75% |
Your call. How does this end?
Free, no money involved. Calls are scored against the market's price when you make them, so backing an underdog that wins scores most. Leaderboard · Your calls
Does the market have this right?
Alert me when the odds move
What counts
The outcome is Yes if the FDA publishes a proposed rule adding BPC-157 or its acetate form to the 503A Bulks List before October 1, 2027. Otherwise, the outcome is No. Readers often mistake the launch of compounded treatments for an official FDA action.
Written from Kalshi's resolution rules by the same model that writes our headlines. The rules on Kalshi are what decides it.
Outcomes
- Yes 75%
- No 25%